Skip to main content
SpringerLink
Log in

Primär refraktäres oder rezidivierendes Mantelzelllymphom

Lange Remissionen unter CAR-T-Zell-Therapie

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur:

  1. Wang M et al. N Engl J Med. 2020;382(14):1331-42

  2. Cheah CY et al. J Clin Oncol. 2016;34(11):1256-69

  3. Robinson SP et al. Bone Marrow Transplant. 2018;53(5):617-24

  4. Kruger SF et al. Clin Pharmacol Ther. 2020;107(1):47-9

  5. Garfall AL et al. N Engl J Med. 2015;373(11):1040-7

  6. Nerreter T et al. Nat Commun. 2019;10(1):3137

  7. Ruella M et al. Nat Med. 2018;24(10):1499-503

  8. Lesch S et al. Semin Cancer Biol. 2019;S1044-579X(19)30219-6

  9. Maude SL et al. N Engl J Med. 2018;378(5):439-48

  10. Neelapu SS et al. N Engl J Med. 2017;377(26):2531-44

Download references

Author information

Authors and Affiliations

  1. Abt. Klin. Pharmakologie \/ Med. Klinik u. Poliklinik IV, Lindwurmstr. 2 A, 80337, München, Deutschland

    Sebastian Kobold

Authors
  1. Sebastian Kobold
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kobold, S. Lange Remissionen unter CAR-T-Zell-Therapie. InFo Hämatol Onkol 23, 39–40 (2020). https://doi.org/10.1007/s15004-020-8142-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-020-8142-0

Search

Navigation